NPT2A Polyclonal Antibody

This gene encodes a member of the type II sodium-phosphate cotransporter family. Mutations in this gene are associated with hypophosphatemia nephrolithiasis/osteoporosis 1. Alternative splicing results in multiple transcript variants.

The NPT2A Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of NPT2A protein expression in various biological samples. This antibody has been meticulously developed using advanced immunization techniques and exhibits exceptional affinity and selectivity towards NPT2A.

The NPT2A Polyclonal Antibody is derived from a diverse pool of immunized animals, ensuring a broad range of epitope recognition and enhanced sensitivity. It has been rigorously validated for its specificity through multiple experimental approaches, including Western blotting, immunohistochemistry, and immunofluorescence.

This antibody demonstrates outstanding performance in detecting NPT2A protein expression in a variety of tissues and cell lines. It exhibits minimal cross-reactivity with other closely related proteins, ensuring accurate and reliable results. The NPT2A Polyclonal Antibody is suitable for use in both research and clinical applications, providing valuable insights into the role of NPT2A in various physiological and pathological processes.

The NPT2A Polyclonal Antibody is supplied as a ready-to-use solution, eliminating the need for time-consuming and complex preparation steps. It is available in various sizes to accommodate different experimental requirements. Each batch of antibody undergoes stringent quality control procedures to ensure consistent and reproducible results.

In summary, the NPT2A Polyclonal Antibody is a highly reliable and efficient tool for the detection and quantification of NPT2A protein expression. Its exceptional specificity, sensitivity, and ease of use make it an invaluable asset for researchers and clinicians alike in unraveling the intricate mechanisms underlying NPT2A-related processes.